<- Go home

Added to YB: 2024-03-01

Pitch date: 2024-03-01

DOCS [bullish]

Doximity, Inc.

-13.75%

current return

Author Info

Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.

Company Info

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

Market Cap

$4.7B

Pitch Price

$28.15

Price Target

N/A

Dividend

N/A

EV/EBITDA

15.99

P/E

21.30

EV/Sales

6.20

Sector

Health Care Technology

Category

turnaround

Show full summary:
(LSE:DOCS) Dr. Martens: Timeless Appeal

DOCS: UK boot brand down 80% from IPO on temporary operational/inventory issues + footwear cycle headwinds, now fixed. Strong brand w/ 13% Instagram engagement (2x competitors), higher NPS scores, multicultural appeal across genders. DTC shift from distributors driving operating leverage. FY25 est: £1B rev, 9% FCF margin, then 4-7% growth. Trading £0.92B vs £1.48B intrinsic value = 60% upside. Risks: fashion/recession.

Read full article (6 min)